Shin D-S, Shon O-J, Byun S-J, Choi J-H, Chun K-A, Cho I-H
Department of Orthopedic Surgery College of Medicine, Yeungnam University, Daegu, Korea.
Skeletal Radiol. 2008 May;37(5):415-21. doi: 10.1007/s00256-008-0462-3. Epub 2008 Feb 29.
To evaluate the efficacy of F-18-fluoro-2-deoxy-D: -glucose positron emission tomography/computed tomography (FDG PET/CT) in differentiating malignant from benign pathologic fractures.
F-18 FDG PET/CT was performed on 34 patients with pathologic fractures between May 2004 and June 2007. Fractures were located in tubular bones (26), in the pelvis (six), in the spine (one) and in a rib (one). The FDG uptake pattern at the fracture site was described, whether FDG uptake occurred in the marrow or cortex and soft tissue. Maximum standardized uptake values (SUVmax, the largest value at the region of interest) were measured at the fracture site, including cortical bone, bone marrow and soft tissue. As a reference standard, biopsy was used for 12 patients and clinical follow-up for 22 patients. Sensitivity, specificity and diagnostic accuracy of PET/CT were calculated.
There were 19 malignant and 15 benign fractures. In the malignant fractures, PET/CT demonstrated high (mean SUVmax 12.0, range 4.3 to 45.7) F-18 FDG uptake in bone marrow in most cases (17 of 19). In benign fractures, there was low FDG uptake (mean SUVmax 2.9, range 0.6 to 5.5) within cortical bone or adjacent soft tissue around the fracture, rarely in the marrow. There were significant differences in the pattern of intramedullary FDG uptake (P < 0.001) and in the mean SUVmax (P < 0.01) between malignant and benign fractures. The sensitivity, specificity and diagnostic accuracy of F-18 FDG PET/CT were 89.5%, 86.7% and 88.2%, respectively, with a cut-off SUVmax set at 4.7. The time interval between fracture and PET/CT did not significantly influence FDG uptake at the fracture site.
F-18 FDG PET/CT reliably differentiated between malignant and benign fractures based on the SUVmax and based on medullary uptake, which was characteristic for malignant fractures.
评估F-18-氟-2-脱氧-D-葡萄糖正电子发射断层扫描/计算机断层扫描(FDG PET/CT)在鉴别病理性骨折的良恶性方面的效能。
2004年5月至2007年6月期间,对34例病理性骨折患者进行了F-18 FDG PET/CT检查。骨折部位位于管状骨(26例)、骨盆(6例)、脊柱(1例)和肋骨(1例)。描述了骨折部位的FDG摄取模式,即FDG摄取是否发生在骨髓、皮质骨和软组织中。在骨折部位测量最大标准化摄取值(SUVmax,感兴趣区域的最大值),包括皮质骨、骨髓和软组织。作为参考标准,12例患者进行了活检,22例患者进行了临床随访。计算PET/CT的敏感性、特异性和诊断准确性。
有19例恶性骨折和15例良性骨折。在恶性骨折中,PET/CT显示大多数病例(19例中的17例)骨髓中F-18 FDG摄取较高(平均SUVmax为12.0,范围为4.3至45.7)。在良性骨折中,骨折周围皮质骨或相邻软组织内FDG摄取较低(平均SUVmax为2.9,范围为0.6至5.5),很少发生在骨髓中。恶性骨折和良性骨折在骨髓内FDG摄取模式(P < 0.001)和平均SUVmax(P < 0.01)方面存在显著差异。F-18 FDG PET/CT的敏感性、特异性和诊断准确性分别为89.5%、86.7%和88.2%,SUVmax临界值设定为4.7。骨折与PET/CT之间的时间间隔对骨折部位的FDG摄取没有显著影响。
F-18 FDG PET/CT基于SUVmax和骨髓摄取情况能够可靠地区分恶性骨折和良性骨折,骨髓摄取是恶性骨折的特征。